ElectromedELMD -1.64%91 Beneish M-Score is -2.31 as of Jun. 25, 2026. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.15 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Electromed ranks worse than 69.58% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.31 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Electromed's Beneish M-Score or its related term are showing as below:
ELMD'
s Beneish M-Score Range Over the Past 10 Years
Min: -3.01 Med: -2.34 Max: -1.86
Current: -2.31
During the past 13 years, the highest Beneish M-Score of Electromed was -1.86. The lowest was -3.01. And the median was -2.34.
Electromed Beneish M-Score Related Terms
Electromed Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Electromed's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Electromed's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Electromed's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Electromed for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.9857
+
0.528 * 0.9887
+
0.404 * 1.2524
+
0.892 * 1.1679
+
0.115 * 0.8271
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 0.9485
+
4.679 * -0.007163
-
0.327 * 1.0596
=
-2.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(0.985 / (0.985 + 5.516))
/
(1.201 / (1.201 + 5.355))
=
0.151515
/
0.183191
=
0.8271
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(10.104 - 0
-
10.53)
/
59.474
=
-0.007163
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Electromed has a M-score of -2.31 suggests that the company is unlikely to be a manipulator.
Electromed (ELMD) has a Beneish M-Score of -2.31 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Electromed and its competitors. According to the industry distribution chart, Electromed ranks #533 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 69.6%.
Is Electromed's Beneish M-Score too high?
Electromed's current Beneish M-Score is -2.31. Based on the distribution chart, Electromed ranks #533 out of 766 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Beneish M-Score compare to MASS and SI?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #533 out of 766 companies for Beneish M-Score. This places Electromed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Electromed and its competitors. Electromed's current Beneish M-Score is -2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.15, compared to a current price of $38.48 — trading 53% above its estimated fair value. The current Beneish M-Score is -2.31. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Electromed (ELMD), the current Beneish M-Score is -2.31 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $38.48 is trading 53% above its estimated GF Value™ of $25.15.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
Beneish M-Score: -2.31
GF Value™: $25.15 vs. price of $38.48 (53% above fair value)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score
Get the complete analysis for ELMD
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
